SK3 Group Announces First Sales of Industry Leadin
Post# of 36729
Posted On: 04/22/2014 9:51:55 AM
SK3 Group Announces First Sales of Industry Leading Medical Cannabis Product T-Hydrocan(TM) RMC 40
LOS ANGELES, CA--(Marketwired - Apr 22, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO) is pleased to announce that the first bottles of its new medicinal cannabis product, T-Hydrocan™ RMC 40, will be available this Wednesday, April 23, 2014, from Pharmajanes.com, and soon thereafter from collectives which carry the YAK Edibles line of medical marijuana products. The "RMC" designation indicates "refined mixed cannabinoids."
T-Hydrocan™ RMC 40 tablets contain 40 mg. of fully activated (decarboxylated) THC, along with the attendant cannabinoids that are found in the cannabis/hemp source material. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids, terpenes, terpenoids, amino acids, and other refined elements of the essential oil of cannabis.
T-Hydrocan™ RMC 40 is packaged 8 tablets per bottle. The suggested retail price is $35.00 per bottle.
T-Hydrocan™ RMC 40 was developed by Berkeley Bio-Organic Research Laboratories, Inc. and is available through Pharmajanes.com and select dispensaries throughout California. The next product in the T-Hydrocan™ product line will be T-Hydrocan™ Whole Plant 25 tablets and capsules.
"We are pleased to get this product to market so quickly," said Artemus Mayor, President of SK3 Group. "Licensing fees from this product will go straight to the company's bottom line and will give patients a high dosage capsule at an affordable price."
LOS ANGELES, CA--(Marketwired - Apr 22, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO) is pleased to announce that the first bottles of its new medicinal cannabis product, T-Hydrocan™ RMC 40, will be available this Wednesday, April 23, 2014, from Pharmajanes.com, and soon thereafter from collectives which carry the YAK Edibles line of medical marijuana products. The "RMC" designation indicates "refined mixed cannabinoids."
T-Hydrocan™ RMC 40 tablets contain 40 mg. of fully activated (decarboxylated) THC, along with the attendant cannabinoids that are found in the cannabis/hemp source material. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids, terpenes, terpenoids, amino acids, and other refined elements of the essential oil of cannabis.
T-Hydrocan™ RMC 40 is packaged 8 tablets per bottle. The suggested retail price is $35.00 per bottle.
T-Hydrocan™ RMC 40 was developed by Berkeley Bio-Organic Research Laboratories, Inc. and is available through Pharmajanes.com and select dispensaries throughout California. The next product in the T-Hydrocan™ product line will be T-Hydrocan™ Whole Plant 25 tablets and capsules.
"We are pleased to get this product to market so quickly," said Artemus Mayor, President of SK3 Group. "Licensing fees from this product will go straight to the company's bottom line and will give patients a high dosage capsule at an affordable price."
(0)
(0)